BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 10798522)

  • 1. Benzodiazepine-induced hyperphagia: development and assessment of a 3D pharmacophore by computational methods.
    Filizola M; Harris DL; Loew GH
    J Biomol Struct Dyn; 2000 Apr; 17(5):769-78. PubMed ID: 10798522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and assessment of a 3D pharmacophore for ligand recognition of BDZR/GABAA receptors initiating the anxiolytic response.
    Harris DL; Loew G
    Bioorg Med Chem; 2000 Nov; 8(11):2527-38. PubMed ID: 11092538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of recognition of ligands binding to benzodiazepine receptor/GABA(A) receptors initiating sedation.
    Harris DL; DeLorey TM; He X; Cook JM; Loew GH
    Eur J Pharmacol; 2000 Aug; 401(3):271-87. PubMed ID: 10936485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a 3D pharmacophore for nonspecific ligand recognition of alpha1, alpha2, alpha3, alpha5, and alpha6 containing GABA(A)/benzodiazepine receptors.
    Filizola M; Harris DL; Loew GH
    Bioorg Med Chem; 2000 Jul; 8(7):1799-807. PubMed ID: 10976528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore, 3D-QSAR, and Bayesian model analysis for ligands binding at the benzodiazepine site of GABAA receptors: the key roles of amino group and hydrophobic sites.
    Yang Y; Zhang W; Cheng J; Tang Y; Peng Y; Li Z
    Chem Biol Drug Des; 2013 May; 81(5):583-90. PubMed ID: 23279907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor.
    Kahnberg P; Howard MH; Liljefors T; Nielsen M; Nielsen EØ; Sterner O; Pettersson I
    J Mol Graph Model; 2004 Dec; 23(3):253-61. PubMed ID: 15530821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a comprehensive pharmacophore model for the benzodiazepine receptor.
    Zhang W; Koehler KF; Zhang P; Cook JM
    Drug Des Discov; 1995 Jan; 12(3):193-248. PubMed ID: 7662830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.
    Vijayan RS; Ghoshal N
    J Mol Graph Model; 2008 Oct; 27(3):286-98. PubMed ID: 18565775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-quinolone derivatives: high-affinity ligands at the benzodiazepine site of brain GABA A receptors. synthesis, pharmacology, and pharmacophore modeling.
    Lager E; Andersson P; Nilsson J; Pettersson I; Nielsen EØ; Nielsen M; Sterner O; Liljefors T
    J Med Chem; 2006 Apr; 49(8):2526-33. PubMed ID: 16610795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.
    Harris D; Clayton T; Cook J; Sahbaie P; Halliwell RF; Furtmüller R; Huck S; Sieghart W; DeLorey TM
    J Med Chem; 2008 Jul; 51(13):3788-803. PubMed ID: 18537233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular determinants of recognition and activation at the cerebellar benzodiazepine receptor site.
    Schove LT; Perez JJ; Loew GH
    Bioorg Med Chem; 1994 Oct; 2(10):1029-49. PubMed ID: 7773620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a new class of pyrrole containing benzodiazepine ligands to the pyrazoloquinolinones CGS 9896, 9895, and 8216.
    Schove LT; Perez JJ; Maguire PA; Loew GH
    Med Chem Res; 1994; 4(5):307-14. PubMed ID: 11539383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudoreceptor models and 3D-QSAR for imidazobenzodiazepines at GABA A/BzR subtypes alphaxbeta3gamma2 [x = 1-3, 5, and 6] via flexible atom receptor model.
    Lu A; Zhou J
    J Chem Inf Comput Sci; 2004; 44(3):1130-6. PubMed ID: 15154782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational changes at benzodiazepine binding sites of GABA(A) receptors detected with a novel technique.
    Berezhnoy D; Baur R; Gonthier A; Foucaud B; Goeldner M; Sigel E
    J Neurochem; 2005 Feb; 92(4):859-66. PubMed ID: 15686488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insight into the central benzodiazepine receptor-ligand interactions: design, synthesis, biological evaluation, and molecular modeling of 3-substituted 6-phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and related compounds.
    Anzini M; Valenti S; Braile C; Cappelli A; Vomero S; Alcaro S; Ortuso F; Marinelli L; Limongelli V; Novellino E; Betti L; Giannaccini G; Lucacchini A; Daniele S; Martini C; Ghelardini C; Di Cesare Mannelli L; Giorgi G; Mascia MP; Biggio G
    J Med Chem; 2011 Aug; 54(16):5694-711. PubMed ID: 21751815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5.
    Chou KC
    Biochem Biophys Res Commun; 2004 Apr; 316(3):636-42. PubMed ID: 15033447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A behaviorally selective class of thiophene-containing benzodiazepine receptor ligands.
    Schove LT; Chen SW; Beatty M; Maguire PA; Davies MF; Loew GH
    Bioorg Med Chem; 1995 Nov; 3(11):1547-61. PubMed ID: 8634835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two neighboring residues of loop A of the alpha1 subunit point towards the benzodiazepine binding site of GABAA receptors.
    Tan KR; Baur R; Gonthier A; Goeldner M; Sigel E
    FEBS Lett; 2007 Oct; 581(24):4718-22. PubMed ID: 17854801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABA(A) receptor subtypes.
    Cooper SJ
    Appetite; 2005 Apr; 44(2):133-50. PubMed ID: 15808888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.